FRESENIUS MEDICAL CARE SERVICES LA RIOJA SL
Location
Rioja, La
Founded
1987-12-28
Website
Risk Signals
154 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Offices and Clinics of Doctors of Medicine), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about FRESENIUS MEDICAL CARE SERVICES LA RIOJA SL
Live alerts from global media, monitored by Business Radar
2025-05-27 (valuespectrum.com)
Formycon and Fresenius Kabi announce the commercial launch of FYB202/Otulfi™, an approved ustekinumab biosimilar in Canada | .com
EQS-News: Formycon AG / Key word(s): Market Launch Formycon and Fresenius Medical Care Kabi announce the commercial launch of FYB202/Otulfi™, an approved ustekinumab biosimilar in Canada 27 - 27 May
Read more